| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |